05-05-2025 17:30 via medpagetoday.com

High-Dose Aflibercept Linked to More Intraocular Inflammation in Real-World Data

(MedPage Today) -- Intraocular inflammation occurred more frequently with 8-mg aflibercept (Eylea) compared with what was observed in previous clinical trials among patients with neovascular age-related macular degeneration (AMD) and diabetic macular...
Read more »

Medical Industry news



Early Rituximab Can Delay Need for Chemo in Follicular Lymphoma
Time to Drop Confirmatory Testing for Primary Aldosteronism?
One-Size-Fits-All Ranges May Be Misclassifying Thyroid Diseases
20 Attorneys General Ask Federal Judge to Reverse Deep Cuts to HHS
Paramagnetic Rim Lesions and Multiple Sclerosis
Who Are the Authors of the HHS Report on Gender Dysphoria?
Is Injection or Surgery Better for Mixed Urinary Incontinence?
Medical Training Lags in Developing Countries. Technology Can Change the Game.
Carpal Tunnel Syndrome: Does It Flag Oncoming Rheumatoid Arthritis?
Why Ask the Question if the Answer Won't Help?
Interventional Cardiology Frets Over Healthcare Policy Threats
SPARTAN Trial: Sparsentan Moves Up to First-Line in IgA Nephropathy
Trump's First 100 Days: Gawande, Offit, Hotez, and Others Weigh In
A Community Rallied to Share Flu Shot Experiences. Then the Gov't Stopped the Study.
Desktop versie